Method for treating thrombocytopenia
US5126325A · kind A · utility
11Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 10, 1990 |
| Grant date | Jun 30, 1992 |
| Priority date | — |
| Expiry date | Jan 10, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Thrombocytopenia is treated by administering to a subject a therapeutic amount of human B cell differentiation factor or its biological equivalent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.